Hasil Pencarian - M. Mol
Anda harus masuk terlebih dahulu
- Menampilkan 1 - 20 hasil dari 41
- Ke Halaman Berikutnya
-
1
Co-Morbid Disorders in Tourette Syndrome oleh Nanette M. M. Mol Debes
Diterbitkan 2013-01-01Dapatkan teks lengkap
Artikel -
2
After the virtual flood: Risk perceptions and flood preparedness after virtual reality risk communication oleh Jantsje M. Mol, W. J. Wouter Botzen, Julia E
Diterbitkan 2022-01-01Dapatkan teks lengkap
Artikel -
3
Differences in Importance Attached to Drug Effects Between Patients With Type 2 Diabetes From the Netherlands and Turkey: A Preference Study oleh Sonia Roldan Munoz, Douwe Postmus, Sieta T. de Vries, Arna H. Arnardottir, İlknur Dolu, Hans Hillege, Hans Hillege, Peter G. M. Mol, Peter G. M. Mol
Diterbitkan 2021-02-01Dapatkan teks lengkap
Artikel -
4
Human keratinocyte sensitivity towards inflammatory cytokines varies with culture time oleh G. Elliott, D. van de Meent, J. van Dijk, M. Mol
Diterbitkan 1992-01-01Dapatkan teks lengkap
Artikel -
5
-
6
-
7
A Review of the Dose Justification of Phase 3 Trials to Regulatory Authorities for Drugs Intended for the Treatment of Type 2 Diabetes in Europe oleh Jeroen V. Koomen, Jeroen V. Koomen, Jasper Stevens, Margje H. Monster-Simons, Margje H. Monster-Simons, Hiddo J. L. Heerspink, Peter G. M. Mol, Peter G. M. Mol
Diterbitkan 2021-04-01Dapatkan teks lengkap
Artikel -
8
-
9
-
10
-
11
Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting oleh Elisabeth Bakker, Peter G. M. Mol, Peter G. M. Mol, Peter G. M. Mol, João Nabais, João Nabais, Thorsten Vetter, Matthias Kretzler, John J. Nolan, Gert Mayer, Anna K. Sundgren, Hiddo J. L. Heerspink, Anja Schiel, Anja Schiel, Sieta T. de Vries, Maria F. Gomez, Friedrich Schulze, Dick de Zeeuw, Michelle J. Pena, for the BEAt-DKD Consortium
Diterbitkan 2021-05-01Dapatkan teks lengkap
Artikel -
12
Precision medicine in regulatory decision making: Biomarkers used for patient selection in European Public Assessment Reports from 2018 to 2020 oleh Elisabeth Bakker, Viktoriia Starokozhko, Jet W. M. Kraaijvanger, Hiddo J. L. Heerspink, Peter G. M. Mol
Diterbitkan 2023-11-01Dapatkan teks lengkap
Artikel -
13
Evaluation of Information in Summaries of Product Characteristics (SmPCs) on the Use of a Medicine in Patients With Hepatic Impairment oleh Rianne A. Weersink, Rianne A. Weersink, Lotte Timmermans, Lotte Timmermans, Margje H. Monster-Simons, Margje H. Monster-Simons, Peter G. M. Mol, Peter G. M. Mol, Herold J. Metselaar, Sander D. Borgsteede, Sander D. Borgsteede, Katja Taxis
Diterbitkan 2019-09-01Dapatkan teks lengkap
Artikel -
14
-
15
-
16
-
17
The effectiveness of intratympanic injections with methylPREDnisolon versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial): a study protocol for a... oleh Berber M Mol, Tjasse D Bruintjes, Peter Paul van Benthem, Maud Martina Emilie Boreel, Babette van Esch, Tjard R Schermer
Diterbitkan 2024-08-01Dapatkan teks lengkap
Artikel -
18
-
19
Sex Proportionality in Pre-clinical and Clinical Trials: An Evaluation of 22 Marketing Authorization Application Dossiers Submitted to the European Medicines Agency oleh Marieke J. H. J. Dekker, Sieta T. de Vries, Sieta T. de Vries, Carolien H. M. Versantvoort, Ellen G. E. Drost-van Velze, Mansi Bhatt, Peter J. K. van Meer, Ineke K. Havinga, Christine C. Gispen-de Wied, Peter G. M. Mol, Peter G. M. Mol
Diterbitkan 2021-03-01Dapatkan teks lengkap
Artikel -
20